HOME >> MEDICINE >> NEWS
Media availability

Meet leaders in cancer research, ask questions and discuss innovative science with the experts.

WHAT: Members of the press are cordially invited to meet with the speakers from AACR's Annual Meeting opening plenary session, taking place 8 a.m. PDT, Sunday, April 17, 2005 at the Anaheim Convention Center, Anaheim, Calif.

WHEN: This media availability will follow the plenary session, which ends at 11:30 a.m. PDT

WHERE: AACR Press Briefing Room, second floor, Anaheim Convention Center, Room 211-A

WHO: Participants in the session include:

Michael B. Kastan, M.D., Ph.D., Cancer Center Director and Chairman, Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tenn. Dr. Kastan is a practicing oncologist whose laboratory research focuses on radiation biology, DNA damage and repair, tumor suppressor genes, determinants of chemosensitivity and radiosensitivity, and causes of cancer. Dr. Kastan made the seminal discovery that the p53 tumor suppressor protein participates in cellular responses to DNA damage. More recently, his lab demonstrated how the ATM protein is activated by DNA damage. Dr. Kastan is the 2005 AACR Annual Meeting Chairperson and, as such, he is chairing the opening plenary session, entitled "The Impact of Scientific Discovery on Cancer Diagnosis and Treatment."

Clifton Leaf, executive editor, Fortune Magazine. Mr. Leaf helps oversee the magazine's editorial coverage and staff, and directs Fortune's Wall Street and investing coverage. His March 22, 2004 cover story, "Why We're Losing the War on Cancer (and How to Win It)," generated much discussion in the cancer research community.

Tyler E. Jacks, Ph.D., the David H. Koch Professor of Biology, the Director of the Center for Cancer Research at MIT, and investigator with the Howard Hughes Medical Institute. Dr. Jack's laboratory has pioneered and constructed a series o
'"/>

Contact: Yarissa Ortiz
ortiz@aacr.org
215-440-9300
American Association for Cancer Research
8-Apr-2005


Page: 1 2 3

Related medicine news :

1. Media coverage of autism differs dramatically
2. Media availability: New results show some severe emphysema patients continue to benefit from surgery
3. Media availability: Drug found to help scleroderma patients
4. Media alert: Register now for the largest obesity conference in North America
5. Media availability: Long-term survival of heart attack patients with shock
6. The IOF World Congress on Osteoporosis (IOF WCO) Opening Media Briefing June 2
7. Webcast: Media coverage of health
8. Media alert: Hazeldens chief medical director available to comment on drug treatment for alcoholics
9. Media telebriefing on new census, NIH status report citing dramatic shifts in US aging
10. Media invitation: 4th International Conference on Teenage and Young Adult Cancer Medicine
11. Media violence linked to concentration, self-control

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Media availability

(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians and ... and musculoskeletal diseases gathered here for the World ... time in the 17-year history of the field’s ... is an emerging non-pharmaceutical protocol for enhancing bone ... Wolff’s law, osteogenic loading at multiples of body ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 An article ... problem which could prove critical to organizations that deal ... a critical aspect of data security, is worsening . ... data security report, every major category out of the ... penetration testing. “With all the craziness that has gone ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 /PRNewswire/ ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces the reporting ... the Company,s Melphalan Hydrochloride for Injection with the ... therapies in a poster presentation at the Society of ...
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
Cached News: